OPEN END TURBO BEAR OPTIONSSCHEIN - ELI LILLY & CO | Market Closed - Börse Stuttgart 03:58:09 2024-07-05 pm EDT | ||
| 6.36 EUR | -16.09% |
|
| Current month | -8.62% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 24-07-05 | 6.36 | -16.09% |
| 24-07-04 | 7.58 | +4.26% |
| 24-07-03 | 7.27 | +2.54% |
| 24-07-02 | 7.09 | +10.78% |
| 24-07-01 | 6.4 | -8.05% |
Delayed Quote Börse Stuttgart
Last update July 05, 2024 at 03:58 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
UniCredit
|
| WKN | HD6BW7 |
| ISIN | DE000HD6BW74 |
| Date issued | 2024-06-14 |
| Strike | 980.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 9.71 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.63 € |
|---|---|
| Lowest since issue | 6.28 € |
| Spread | 0.12 € |
| Spread % | 1.85% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
914.6
USD
Average target price
870.3
USD
Spread / Average Target
-4.84%
- Stock Market
- Certificates
- Certificat
